DUBLIN, Calif., Oct. 22 SuperGen Inc.(Nasdaq: SUPG), a pharmaceutical company dedicated to the discovery, rapiddevelopment and commercialization of therapies for solid tumors andhematological malignancies, today announced that it will release its 2007third quarter financial results on Monday, Oct. 29, 2007. SuperGen Managementwill provide details on the Company's 2007 third quarter financial results,and any revised outlook for the future.
A press release will be transmitted to the news media immediatelyfollowing the close of the market on Oct. 29. The Company will host aconference call and webcast to discuss the results at 4:30 p.m. ET / 1:30 p.m.PT. The webcast is accessible via the investor relations section of theCompany's Web site at www.supergen.com. A webcast replay of the liveconference call will be available for 90 days.
Based in Dublin, Calif., SuperGen, Inc. is a pharmaceutical companydedicated to the discovery, rapid development and commercialization oftherapies for solid tumors and hematological malignancies. SuperGen isdeveloping a number of therapeutic anticancer products focused on kinase andcell signaling inhibitors and DNA methyltransferase inhibitors. For moreinformation about SuperGen, please visit http://www.supergen.com.Contacts: SuperGen SuperGen Timothy L. Enns Mary M. Vegh S.V.P., Corporate Communications Manager, Investor Relations & Business Development (925) 560-2845 (925) 560-0100 x111 [email protected] [email protected]
SOURCE SuperGen Inc.